HU9301509D0 - Tnf inhibitors - Google Patents

Tnf inhibitors

Info

Publication number
HU9301509D0
HU9301509D0 HU931509A HU150993A HU9301509D0 HU 9301509 D0 HU9301509 D0 HU 9301509D0 HU 931509 A HU931509 A HU 931509A HU 150993 A HU150993 A HU 150993A HU 9301509 D0 HU9301509 D0 HU 9301509D0
Authority
HU
Hungary
Prior art keywords
tnf inhibitors
tnf
inhibitors
Prior art date
Application number
HU931509A
Other languages
Hungarian (hu)
Other versions
HUT65838A (en
Inventor
Klaus Max Esser
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of HU9301509D0 publication Critical patent/HU9301509D0/en
Publication of HUT65838A publication Critical patent/HUT65838A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU9301509A 1990-11-21 1991-11-20 Pharmateutical preparations containing tnf inhibitors HUT65838A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61647990A 1990-11-21 1990-11-21

Publications (2)

Publication Number Publication Date
HU9301509D0 true HU9301509D0 (en) 1993-11-29
HUT65838A HUT65838A (en) 1994-07-28

Family

ID=24469639

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9301509A HUT65838A (en) 1990-11-21 1991-11-20 Pharmateutical preparations containing tnf inhibitors

Country Status (14)

Country Link
EP (1) EP0558659A4 (en)
JP (1) JP3204971B2 (en)
KR (1) KR930702896A (en)
AP (1) AP259A (en)
AU (1) AU656938B2 (en)
CA (1) CA2096623A1 (en)
HU (1) HUT65838A (en)
IE (1) IE914034A1 (en)
IL (1) IL100088A (en)
MX (1) MX9102173A (en)
NZ (1) NZ240644A (en)
TW (1) TW222001B (en)
WO (1) WO1992009203A1 (en)
ZA (1) ZA919178B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1531492A (en) * 1991-02-14 1992-09-15 Rockefeller University, The Method for controlling abnormal concentration tnf alpha in human tissues
WO1995004525A2 (en) * 1993-08-04 1995-02-16 Andrulis Pharmaceuticals Corporation Use of tumor necrosis factor inhibitors together with antiviral agents and therapeutic compositions thereof against hiv infection
US5504090A (en) * 1994-03-30 1996-04-02 Trustees Of The University Of Pennsylvania Compositions and methods for the prevention and treatment of ischemia-reperfusion organ injury
US7608262B2 (en) * 1996-02-16 2009-10-27 The Kennedy Institute Of Rheumatology Methods of preventing or treating thrombosis with tumor necrosis factor antagonists
GB9703044D0 (en) 1997-02-14 1997-04-02 Glaxo Group Ltd Phenyl xanthine esters and amides
GB9817623D0 (en) 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
JP2006508996A (en) * 2002-11-27 2006-03-16 アルタナ　ファルマ　アクチエンゲゼルシャフト PDE4 and PDE3 / 4 inhibitors for use in the treatment of cachexia
PT1781657E (en) * 2004-02-14 2013-05-23 Glaxosmithkline Ip Dev Ltd Medicaments with hm74a receptor activity
SI1912991T1 (en) 2005-08-10 2011-03-31 Glaxosmithkline Llc One Franklin Plaza Xanthine derivatives as selective hm74a agonists
EP3205652B1 (en) 2014-10-09 2022-03-09 Guangdong Raynovent Biotech Co., Ltd. Hydroxyl purine compounds and applications thereof
US10399981B2 (en) 2015-10-29 2019-09-03 Guangdong Raynovent Biotech Co., Ltd. Crystal form A of 7-(cyclopropylmethyl)-1-(((cis )-4-hydroxy-4-methylcyclohexyl)methyl)-3-methyl-1H-purine-2,6-(3H,7H)-dione for treating liver diseases

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US757328A (en) * 1903-02-07 1904-04-12 Boehringer & Soehne Art of preparing xanthin derivatives.
US2517410A (en) * 1947-08-15 1950-08-01 Searle & Co Hydroxy alkyl xanthines and the production thereof
US4120947A (en) * 1976-03-31 1978-10-17 Cooper Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases
CH654008A5 (en) * 1979-05-22 1986-01-31 Nestle Sa PROCESS FOR THE PREPARATION OF 1,3,7-TRIALKYLXANTHINES.
DE2944568A1 (en) * 1979-11-05 1981-05-14 Institut für industrielle Pharmazie F + E GmbH, 8750 Aschaffenburg Sodium 8-chloro-theophyllinate as immunostimulant - which selectively stimulates formation of IGM antibodies
IT1200944B (en) * 1982-08-10 1989-01-27 Malesci Sas XANTHINIC DERIVATIVES, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT AND THEIR THERAPEUTIC USE
US4593095A (en) * 1983-02-18 1986-06-03 The Johns Hopkins University Xanthine derivatives
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
GB8610136D0 (en) * 1986-04-25 1986-05-29 Wellcome Found Compounds
IT1197516B (en) * 1986-12-24 1988-11-30 Abc Ist Biolog Chem Spa THEOFILLINMETYLANIC AND THEOFILLINMETYLDITIAN DERIVATIVES PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5015647A (en) * 1987-04-24 1991-05-14 Burroughs Wellcome Co. Method for treating viral infections
DE3817955A1 (en) * 1988-05-27 1989-11-30 Hoechst Ag MEDICINAL PRODUCT CONTAINING TNF INHIBITOR
FI891419A (en) * 1989-03-23 1990-09-24 Tampella Oy Ab ANORDNING I EN GAENGOEPPNINGSANORDNING FOER BORRMASKINERI.
GB8906792D0 (en) * 1989-03-23 1989-05-10 Beecham Wuelfing Gmbh & Co Kg Treatment and compounds

Also Published As

Publication number Publication date
AU9115991A (en) 1992-06-25
IL100088A0 (en) 1992-08-18
TW222001B (en) 1994-04-01
MX9102173A (en) 1992-06-01
JPH06506192A (en) 1994-07-14
JP3204971B2 (en) 2001-09-04
EP0558659A4 (en) 1993-10-20
AP9100335A0 (en) 1992-01-31
IE914034A1 (en) 1992-06-03
HUT65838A (en) 1994-07-28
NZ240644A (en) 1994-08-26
AU656938B2 (en) 1995-02-23
CA2096623A1 (en) 1992-05-22
KR930702896A (en) 1993-11-29
WO1992009203A1 (en) 1992-06-11
EP0558659A1 (en) 1993-09-08
IL100088A (en) 1995-07-31
AP259A (en) 1993-06-03
ZA919178B (en) 1992-10-28

Similar Documents

Publication Publication Date Title
SG46381A1 (en) Leukoriene biiosynthese inhibitor
GB9116684D0 (en) Corrosion inhibitors
EP0746367A4 (en) Easy intubator
AU8292091A (en) Tnf inhibitors
ZA922420B (en) Grf-analogs ii
BG95816A (en) New sulphonylcarbamides
ZA925051B (en) Corrosion inhibitors
GB9200551D0 (en) Suspensory
ZA912498B (en) Novel platelet-aggregation inhibitors
IL100088A0 (en) Tnf inhibitors
GB2244944B (en) Vice
ZA931222B (en) TNF inhibitors
GB9122735D0 (en) Methods
IL99953A0 (en) Ester inhibitors
EP0543936A4 (en) Renin inhibitors
GB9122721D0 (en) Methods
GB2259570B (en) Spirit level
ZA916059B (en) Tnf inhibitors
GB9026251D0 (en) Netalloproteinase inhibitors
ZA914716B (en) Ace inhibitors
CA68400S (en) Block
CA69300S (en) Block
IE893832L (en) DOPAMINE-ß-HYDROXYLASE INHIBITORS
ZA911921B (en) Scraper
AU115316S (en) Level

Legal Events

Date Code Title Description
DFC4 Cancellation of temporary protection due to refusal